Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51

MEDIA ADVISORY: Workers say ‘Enough is Enough’ as 18-02-2023, 00:02

Esteemed Excellence: C.K. McWhorter & McWhorter Family Trust Illuminates Aqua Panna Natural Mineral Water’s Timeless Legacy with McWhorter Family 25-03-2024, 02:32